Get the Stockscreener App
68.24
0.47%
-0.32
Pre-market:
72.00
3.76
+5.51%
Arcellx Inc Stock (ACLX) Latest News
Kavita Patel Sells 1,500 Shares of Arcellx, Inc. (NASDAQ:ACLX) Stock - Armenian Reporter
Arcellx, Inc. (NASDAQ:ACLX) Director Sells $96,855.00 in Stock - MarketBeat
Taking a Closer Look At Arcellx Inc (ACLX) Following Its Recent Trade - Knox Daily
Financial Review: Arcellx (NASDAQ:ACLX) versus C4 Therapeutics (NASDAQ:CCCC) - Defense World
arcellx director kavita patel sells $96,854 in stock - MSN
arcellx director kavita patel sells $96,854 in stock By Investing.com - Investing.com Australia
(ACLX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Arcellx (NASDAQ:ACLX) Stock Price Down 5.4%Should You Sell? - MarketBeat
Brokerages Set Arcellx, Inc. (NASDAQ:ACLX) PT at $105.93 - MarketBeat
Moody Aldrich Partners LLC Sells 16,122 Shares of Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Short Interest Update - MarketBeat
Analysts Set Arcellx, Inc. (NASDAQ:ACLX) PT at $105.93 - Defense World
Vanguard Group Inc's Strategic Acquisition of Arcellx Inc Shares - GuruFocus.com
Stifel maintains Buy on Arcellx shares, target at $122 - MSN
Stifel maintains Buy on Arcellx shares, target at $122 By Investing.com - Investing.com Canada
(ACLX) On The My Stocks Page - Stock Traders Daily
Cantor Fitzgerald Estimates Arcellx FY2025 Earnings - Defense World
Brokers Issue Forecasts for Arcellx FY2025 Earnings - MarketBeat
Arcellx, Inc. (NASDAQ:ACLX) Sees Significant Growth in Short Interest - Defense World
Short Interest in Arcellx, Inc. (NASDAQ:ACLX) Expands By 6.6% - MarketBeat
Arcellx, Inc.: Trying To Build A Better Myeloma Cell Therapy - Seeking Alpha
Arcellx director Kavita Patel sells $98,801 in stock By Investing.com - Investing.com Australia
Arcellx, Inc. (NASDAQ:ACLX) Director Kavita Patel Sells 1,500 Shares - MarketBeat
Arcellx director Kavita Patel sells $98,801 in stock - Investing.com India
(ACLX)Analyzing Arcellx's Short Interest - Benzinga
Oversold Conditions For Arcellx (ACLX) - Nasdaq
Arcellx, Inc. (NASDAQ:ACLX) Insider Sells $261,820.57 in Stock - MarketBeat
Arcellx's chief medical officer sells shares worth $581,315 By Investing.com - Investing.com Australia
arcellx CEO Elghandour sells stock worth $2.26 million By Investing.com - Investing.com Nigeria
Arcellx CFO Michelle Gilson sells shares worth $700,959 By Investing.com - Investing.com Australia
arcellx CEO Elghandour sells stock worth $2.26 million - Investing.com
Arcellx CFO Michelle Gilson sells shares worth $700,959 - Investing.com India
Arcellx Breaks Below 200-Day Moving AverageNotable for ACLX - Nasdaq
Arcellx's chief medical officer sells shares worth $581,315 - Investing.com
JPMorgan Chase & Co. Sells 38,336 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Receives $105.93 Consensus Price Target from Brokerages - Defense World
Arcellx's chief medical officer sells shares worth $498,795 By Investing.com - Investing.com Australia
Arcellx CFO Michelle Gilson sells $831,378 in stock By Investing.com - Investing.com Nigeria
Principal Financial Group Inc. Has $336,000 Stock Position in Arcellx, Inc. (NASDAQ:ACLX) - MarketBeat
Arcellx CEO Rami Elghandour sells shares worth $2.24 million By Investing.com - Investing.com Australia
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):